Since that initial discovery, ACVR2B/Fc has been evaluated in a number of pre-clinical studies of both cancer and chemotherapy-induced cachexia with significant preservation of skeletal muscle [15,16,17,18,19,20,21,22]. Here, ACVR2B is linked to Cachexia.